1-2 of 2
Michele Ghielmini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I-II Study to Determine the Maximum Tolerated Infusion Rate of Rituximab with Special Emphasis on Monitoring the Effect of Rituximab on Cardiac Function

Free
Marco Siano, Erika Lerch, Laura Negretti, Emanuele Zucca, Delvys Rodriguez-Abreu, Michel Oberson, Leda Leoncini, Oreste Mora, Cristiana Sessa, Augusto Gallino, Michele Ghielmini
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (23): 7935–7939.
https://doi.org/10.1158/1078-0432.CCR-08-1124
Published: 01 December 2008
View articletitled, A Phase I-II Study to Determine the Maximum Tolerated Infusion Rate of Rituximab with Special Emphasis on Monitoring the Effect of Rituximab on Cardiac Function
Open the PDF for A Phase I-II Study to Determine the Maximum Tolerated Infusion Rate of Rituximab with Special Emphasis on Monitoring the Effect of Rituximab on Cardiac Function in another window
Journal Articles

Phase I and Pharmacokinetic Study of the New Taxane Analog BMS-184476 Given Weekly in Patients with Advanced Malignancies

Free
Ruth Plummer, Michele Ghielmini, Paula Calvert, Maurizio Voi, Josette Renard, Gilles Gallant, Elora Gupta, Hilary Calvert, Cristiana Sessa
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (9): 2788–2797.
Published: 01 September 2002
View articletitled, Phase I and Pharmacokinetic Study of the New Taxane Analog BMS-184476 Given Weekly in Patients with Advanced Malignancies
Open the PDF for Phase I and Pharmacokinetic Study of the New Taxane Analog BMS-184476 Given Weekly in Patients with Advanced Malignancies in another window